Evidence map›Paper›PMID 40980658›Full record

ArticleKidney international reports2025

Rationale and Design of the International Prospective Study of CKD of Uncertain Etiology in Agricultural Communities.

Jill F Lebov, Daniel R Brooks, Anna Aceituno, Hildaura Acosta, Juan Amador Velázquez, Shuchi Anand, Aurora Aragón, Mariela Arias-Hidalgo, Vivek Bhalla, Karen Courville and 27 more

Abstract read
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Mesoamerican nephropathy as a potential contributor to chronic allograft dysfunction in tropical settings.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Jill F LebovSocial Statistical and Environmental Sciences Division, RTI International, Research Triangle Park, North Carolina, USA.
Daniel R BrooksDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
Anna AceitunoSocial Statistical and Environmental Sciences Division, RTI International, Research Triangle Park, North Carolina, USA.
Hildaura AcostaFacultad de Medicina, Centro de Investigación e Información de Medicamentos y Tóxicos (CIIMET), Vicerrectoría de Investigación y Postgrado, Universidad de Panamá, Panamá, República de Panamá.
Juan Amador VelázquezDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
Shuchi AnandDivision of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Aurora AragónWuqu' Kawoq Maya Health Alliance, Sacatepéquez, Guatemala.
Mariela Arias-HidalgoEscuela de Medicina, Universidad de Costa Rica, San José, Costa Rica.
Vivek BhallaWuqu' Kawoq Maya Health Alliance, Sacatepéquez, Guatemala.
Karen CourvilleHospital Dr. Gustavo Nelson Collado, Nefrología, Jefe Unidad de Hemodiálisis, Herrera, República de Panamá.
Jennifer CroweRegional Institute for Studies on Toxic Substances, Universidad Nacional de Costa Rica, Heredia, Costa Rica.
Idalina Cubilla-BatistaHospital Regional Dr. Rafael Estevez, Coclé, República de Panamá.
Lawrence S EngelDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
Nora FranceschiniDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
David J FriedmanMedicine/Renal, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Ramón Garcia-TrabaninoAgency for Agricultural Development and Health, San Salvador, El Salvador.
Marvin González-QuirozDepartment of Environmental and Occupational Health, School of Public Health, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Balaji GummidiGeorge Institute for Global Health, University of New South Wales, New Delhi, India.
Carolina Guzmán-QuiloDepartamento de Toxicología, Facultad de Ciencias Químicas y Farmacia, Universidad de San Carlos de Guatemala, Ciudad de Guatemala, Guatemala.
Vivekanand JhaGeorge Institute for Global Health, University of New South Wales, New Delhi, India.
Bonnie R JoubertDivision of Extramural Research and Training Durham, National Institute of Environmental Health Sciences, North Carolina, USA.
Karen KeslerSocial Statistical and Environmental Sciences Division, RTI International, Research Triangle Park, North Carolina, USA.
Adeera LevinDepartment of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Indiana Mercedes López-BonillaWuqu' Kawoq Maya Health Alliance, Sacatepéquez, Guatemala.
Susan R MendleyDivision of Kidney, Urologic and Hematologic Disease, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.
Sumit MohanRenal Division, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Ana Navas-AcienDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York, USA.
Afshin ParsaDivision of Kidney, Urologic and Hematologic Disease, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.
Peter RohloffDivision of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Emmanuel Jarquin RomeroAgency for Agricultural Development and Health, San Salvador, El Salvador.
Clemens RuepertRegional Institute for Studies on Toxic Substances, Universidad Nacional de Costa Rica, Heredia, Costa Rica.
Vicente Sánchez-PoloInstituto Guatemalteco de Seguridad Social, Nefrologia, Guatemala City, Guatemala.
Madeleine K ScammellDepartment of Environmental Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Karla Solano-DiazRegional Institute for Studies on Toxic Substances, Universidad Nacional de Costa Rica, Heredia, Costa Rica.
Lillian TrochinskiSocial Statistical and Environmental Sciences Division, RTI International, Research Triangle Park, North Carolina, USA.
Alexander van GeenGeochemistry Division, Columbia Climate School, Columbia University, Lamont-Doherty Earth Observatory (LDEO), New York, New York, USA.
Sushrut S WaikarSection of Nephrology, Boston Medical Center and Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.

Funding

Discovery Science Collaborative for CKDuU01DK130060 · NIDDK · STANFORD UNIVERSITY · PI VIVEK BHALLA, David J Friedman · 2021 to 2026
$5.7M
The Chorotega CKDu Epidemiology Field StudyU01DK130044 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Mariela Arias-Hidalgo, LAWRENCE STUART ENGEL · 2021 to 2026
$2.9M
CKDu in Salvadoran and Nicaraguan Agricultural CommunitiesU01DK130057 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Madeleine Scammell · 2021 to 2026
$2.8M
Exploring risk factors and predictors of endemic CKDu in agricultural regions of four Central America countriesU01DK130046 · NIDDK · UNIVERSIDAD NACIONAL, COSTA RICA · PI Jennifer Crowe, MARVIN GONZALEZ-QUIROZ · 2021 to 2026
$2.8M
NIDDK NIH HHS U01 DK130044NIDDK NIH HHS U01 DK130046NIDDK NIH HHS U01 DK130057NIDDK NIH HHS U01 DK130060
6 · The paper itself

Abstract

Introduction: There has been an alarming increase in the incidence of a chronic kidney disease (CKD) of unknown etiology primarily affecting young individuals engaged in agricultural activities in Mesoamerica and South Asia. Despite extensive research over the past 2 decades, causes remain unclear. The disease is characterized by progressive loss of kidney function with the absence of heavy proteinuria and hematuria. The International Prospective Study of CKD of Unknown Etiology in Agricultural Communities (CURE study) aims to do the following: (i) identify factors associated with kidney function decline among individuals with or at risk for CKD of uncertain etiology (CKDu); (ii) better characterize the clinical phenotypes of individuals with CKDu and differentiate them from other forms of CKD; (iii) employ advanced laboratory and data analysis methods to conduct discovery science related to risk factors, biomarkers, and causal mechanisms; and (iv) establish a biorepository for future research. Methods: The CURE study is a prospective cohort study of up to 3600 participants from 7 sites in Central America and India aged 18 to 45 years with estimated glomerular filtration rate (eGFR) ≥ 20 ml/min per 1.73 m Results: Blood, urine, and hair will be analyzed for kidney function biomarkers, trace elements, pesticides and other contaminants, untargeted metabolomics, and genetic assays. Environmental samples, collected from a subset of study participants, will be analyzed for trace elements, agrochemicals, and burning exposures. Conclusion: This study will provide novel information about CKDu etiology and clinical phenotypes across distinct geographies.

Indexed as

chronic interstitial nephritis in agricultural communities (CINAC)chronic kidney diseaseCKDucohort studyMesoamerican nephropathystudy design

Identifiers

PMID40980658
PMCPMC12446941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.